Clinical Trial Update: First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 trial update for first-line treatment of stage IV nonsquamous non-small cell lung cancer using necitumumab with pemetrexed-cisplatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Necitumumab (necitumumab)
• Pemetrexed/cisplatin

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27